May 9, 2019 07:02AM
May 9, 2019 07:02AM
Mar 14, 2019 04:59PM
Mar 14, 2019 04:57PM
Feb 28, 2019 07:00AM
Feb 28, 2019 07:00AM
Feb 27, 2019 06:24AM Karyopharm (KPTI) Confirms Panel Recommended FDA Wait for Results from Phase 3 BOSTON Study of Selinexor in Patients R/R MM before Making Final Decision on Approval
Feb 26, 2019 05:47PM
Feb 26, 2019 05:47PM
Feb 26, 2019 12:33PM
Feb 26, 2019 12:31PM
Feb 26, 2019 12:31PM
Feb 7, 2019 07:48AM
Feb 7, 2019 07:00AM Karyopharm Announces FDA Advisory Committee Meeting to Review Selinexor for the Treatment of Patients with Triple Class Refractory Multiple Myeloma Who Have Received At Least Three Prior Therapies
Feb 7, 2019 07:00AM
Oct 5, 2018 05:43PM
Oct 5, 2018 05:43PM
May 2, 2018 09:24AM
May 1, 2018 06:33PM
Sep 6, 2016 12:56PM

15,404 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All